Adenosine produces analgesia in the spinal cord and can be formed extracellularly through enzymatic conversion of adenine nucleotides. A transverse push±pull microprobe was developed and characterized to sample extracellular adenosine concentrations of the dorsal horn of the rat spinal cord. Samples collected via this sampling technique reveal that AMP is converted to adenosine in the dorsal horn. This conversion is decreased by the ecto-5 H -nucleotidase inhibitor, a,b-methylene ADP. Related behavioral studies demonstrate that AMP administered directly to the spinal cord can reverse the secondary mechanical hyperalgesia characteristic of the intradermal capsaicin model of in¯ammatory pain. The speci®c adenosine A 1 receptor antagonist 8-cyclopentyl-1,3-dimethylxanthine (CPT) inhibits the antihyperalgesia produced by AMP. This research introduces a novel microprobe that can be used as an adjunct sampling technique to microdialysis and push±pull cannulas. Furthermore, we conclude that AMP is converted to adenosine in the dorsal horn of the spinal cord by ecto-5 H -nucleotidase and subsequently may be one source of adenosine, acting through adenosine A 1 receptors in the dorsal horn of the spinal cord, which produce antihyperalgesia.
Adenosine and adenosine analogs, such as 2-chloroadenosine, N 6 -cyclohexyladenosine and N 6 -(R-phenylisopropyl)-adenosine, produce analgesia in normal animals and antihyperalgesia in injured animals (DeLander and Hopkins 1987; Doi et al. 1987; DeLander and Wahl 1988; Sawynok and Sweeney 1989; Keil and DeLander 1994; Lavand'homme and Eisenach 1999) . These effects can be blocked by non-speci®c adenosine receptor antagonists (Sawynok et al. 1986; ) and speci®c adenosine A 1 receptor antagonists (Lee and Yaksh 1996; Cui et al. 1997; Poon and Sawynok 1998) administered directly to the spinal cord. Intrathecal adenosine has recently been shown to decrease tactile allodynia in patients with chronic neuropathic pain (Belfrage et al. 1999) .
Several hypotheses exist concerning the source of extracellular adenosine. This subject is an area of debate and, although more than one hypothesis may be correct, little consensus has been reached. One hypothesis involves the intracellular metabolism of cyclic AMP to adenosine (Orford and Saggerson 1996) . Adenosine is then transported outside of the cell via adenosine transporters that have been identi®ed and can be blocked by adenosine transporter inhibitors (Salter et al. 1993; Sweeney et al. 1993; White 1996) . Secondly, an internal store of adenosine is hypothesized to be released by either neurons or glia or both (Sweeney 1996) . A third hypothesis implies the conversion of intracellular cyclic AMP to AMP; the AMP is secreted and then converted to adenosine extracellularly (Rosenberg and Li 1996) . A fourth hypothesis suggests that released ATP is a source of adenosine. ATP is often co-released with neurotransmitters, and its extracellular metabolism is thought to be a source of the neuromodulator adenosine 234 q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 76, 234±246 (James and Richardson 1993) . Finally, extracellular cyclic AMP is hypothesized to be a source of adenosine via extracellular metabolism. In cell lines (Bruns 1980a ) and hippocampal pyramidal neurons (Dunwiddie et al. 1997 ) it has been demonstrated that the conversion of nucleotides to adenosine is a more likely source of adenosine than direct release per se. All of the metabolic pathways that produce adenosine involve the metabolism of AMP to adenosine by the enzyme, ecto 5 H -nucleotidase. This metabolic step has been investigated in skeletal muscle, adipose tissue, kidney, striatum and in cell culture (Bruns 1980a; Gordon et al. 1986; Cunha and Sebastia Äo 1991; Lai and Wong 1991; Rosenberg 1992; Mi and Jackson 1995; Carey et al. 1996) . ecto-5 H -nucleotidase is immunolocalized to the surface of cells (Rosenberg 1992) and to the spinal cord (Salter et al. 1993) , and can be inhibited by enzyme inhibitors (James and Richardson 1993) such as a,b-methylene ADP (White 1996) . This paper describes the development and characterization of a new sampling technique that can be used to investigate the hypothesis that AMP is enzymatically converted to adenosine in the dorsal horn of the spinal cord. Additionally, we demonstrate that AMP reverses the secondary mechanical hyperalgesia produced by intradermal capsaicin in the rat hindpaw. The antihyperalgesic action of AMP is blocked by a speci®c-to-adenosine A 1 receptor antagonist.
Materials and methods

In vitro characterization of microprobes
Construction of transverse push±pull microprobes
A 5-cm length of 125-mm tungsten wire (Small Parts, Inc., Miami Lakes, FL, USA) was ®xed with epoxy resin to a 20-cm segment of Filtral AN 69 HF microdialysis ®ber (Hospal Industrie/Gambro, Lakewood, CO, USA). A 0.5-, 1.0-or 2.0-mm section of the epoxy coated ®ber was cut out and a wire guide cannulae inserted into the ®ber.
A Harvard Apparatus PhD 2000 Infuse/Withdraw pump (Holliston, MA, USA) accommodated two push and two pull syringes. Two distribution values were used to switch the¯ow between syringes, thereby permitting uninterrupted solution¯ow. The¯ow pattern is illustrated in Fig. 1 . Continuous solution¯ow is critical to minimize blockage or collapse of probe tips. For all characterization experiments, the¯ow rate of the push±pull pump was set at 20, 10 or 5 mL/min, and samples were collected for 5, 10, or 20 min, respectively. Differences between the push and pull ow rates ranged between 0.12 and 0.25 mL/min.
Microprobe characterization
Microprobes were threaded through holes in 0.5-mL polypropylene microcentrifuge tubes and held in place by epoxy resin. For recovery of analyte experiments, microcentrifuge tubes were ®lled with 64-mm p-nitrophenol and the push syringe contained 0.155-m glycine buffer, pH 8.9, with 1.55-mm MgCl 2 and 1.55-mm ZnCl 2 (Worthington 1988) . For recovery of substrate experiments, push syringes were ®lled with the p-nitrophenol solution and the microcentrifuge tubes were ®lled with glycine buffer.
The concentration of the p-nitrophenol collected during either analyte-recovery or substrate-recovery experiments was determined by an absorbance measurement at 405 nm. Absorbances were obtained in standard 1-cm methacrylate cuvets with an OLIS modi®ed Cary-14 double beam spectrophotometer (On-Line Instrument Systems, Inc., Bogart, GA, USA). Concentrations were obtained by interpolation from standard curves. Analyte and substrate recoveries were compared with those obtained with microdialysis ®bers prepared with a 2-mm active area and a push± pull cannula (outer diameter 0.56 mm) purchased from Plastics One, Inc. (Roanoke, VA, USA).
Enzyme activity measurements
The transverse push±pull microprobe was evaluated as a method for measuring in situ enzyme activity levels. This evaluation used a microcentrifuge tube ®lled with alkaline phosphatase (ALP; ecto-5 H -nucleotidase) immobilized within a sol-gel matrix (Ingersoll and Fig. 1 Diagram of continuous¯ow design. Two push syringes are connected into a four-port distribution valve so that perfusion solutions can be changed without interrupting the¯ow through the microprobe. Two pull syringes are connected to a four port distribution valve so that one syringe can be removed and the sample transferred into a microcentrifuge tube while another sample is being collected into the second syringe. The microprobe is shown as it was positioned in the dorsal spinal cord. The gap was off center so that it would overlay one of the dorsal horns.
Bright 1997). Sol-gels were prepared by sonicating a solution composed of 625 mL tetramethyl orthosilicate, 370 mL water, and 8.5 mL 0.01-m hydrochloric acid for 30 min (Aylott et al. 1997) . After sonication, 1 mL of 0.05 mg/mL ALP in Tris-HCl (pH 8.5) was added. Sol-gels were poured into a 0.5-mL microcentrifuge tube pierced transversely with a 22-G needle and allowed to solidify. Control sol-gels were prepared in an identical manner except that ALP was not present in the Tris-HCl buffer. Once formed, sol-gels were kept hydrated with glycine buffer. The needle was removed and a microprobe inserted through the channel and secured with epoxy resin. Ends of the microprobe were connected to the syringes on the push±pull pump by short lengths of polypropylene tubing (PE20, inner diameter 0.38 mm, outer diameter 1.09 mm, Becton Dickinson and Company, Franklin Lakes, NJ, USA). The ability to measure activity of immobilized ALP was assessed for three microprobe gap distances, and three¯ow rates were tested with each gap distance. The experiment involved¯owing a solution of 484 mm p-nitrophenylphosphate through the microprobe. A fraction of the p-nitrophenylphosphate exiting the push side of the probe interacts with ALP and is converted to p-nitrophenol. The amount of p-nitrophenol in the collected¯uid was determined by an absorbance measurement.
ALP activity in the collected¯uid was measured in order to account for the effect of unbound, soluble enzyme. The ALP activity in the collected¯uid was used to determine the amount of p-nitrophenol produced from this soluble enzyme during the period after the active probe region and before collection. The number of moles of p-nitrophenol produced from this soluble enzyme was subtracted from the p-nitrophenol measured in the collected¯uid. The amount of p-nitrophenol produced from soluble enzyme is presented as a percentage of the total p-nitrophenol contained in the collected samples.
Finally, the total amount of collected p-nitrophenylphosphate was determined. After determining the amount of p-nitrophenol in the collected¯uid, an aliquot of ALP was added, the solutions incubated overnight and the p-nitrophenol concentrations obtained again. The amount of unreacted p-nitrophenylphosphate in each sample was computed as the difference between the p-nitrophenol measured before and after adding ALP to the sample.
Statistical analysis
A two-way anova followed by Tukey's post hoc comparisons were used to determine signi®cant effects of gap distance and¯ow rate on the analyte recovery and substrate recovery. Additionally, these statistical tests were used to evaluate the effects of gap distance and ow rate on product recovery, substrate recovery, substrate loss and product arising from conversion by soluble enzyme for the ALP sol-gel model of the spinal cord. Finally, paired t-tests were used to compare product recovery, substrate recovery and substrate loss for ALP and control sol-gels.
AMP conversion to adenosine in vivo
Animals
Male Sprague±Dawley rats (Harlan, Indianapolis, IN, USA) weighing 250±300 g were housed in temperature controlled conditions with a 12-h light/dark cycle. Experiments involving these animals were approved by the Animal Care and Use Committee at The University of Iowa.
Drugs and chemicals
Nembutal w sodium solution (sodium pentobarbital, 50 mg/mL) was purchased from Abbott Laboratories (North Chicago, IL, USA) and atropine sulfate (0.4 mg/mL) was purchased from American Pharmaceutical Partners, Inc. (Los Angeles, CA, USA). Arti®cial cerebrospinal¯uid (ACSF) was prepared with HPLC-grade water (EM Science, Gibbstown, NJ, USA). All other chemicals were purchased from Sigma (St. Louis, MO, USA) or Aldrich (Milwaukee, WI, USA).
ACSF was prepared with slight modi®cations to a published recipe (Sluka 1997b ) and contained 1.30 mm calcium chloride dihydrate, 2.59 mm potassium chloride, 0.90 mm magnesium chloride heptahydrate, 20.9 mm sodium bicarbonate, 2.50 mm sodium hydrogen phosphate heptahydrate, 124 mm sodium chloride and 3.82 mm glucose. The prepared ACSF was bubbled with 95% O 2 , 5% CO 2 , vacuum ®ltered through 0.2-mm nylon ®lters (Whatman, Clinton, NJ, USA) and adjusted to pH 7.2±7.4.
For push±pull experiments, AMP (0.3, 1 and 3 mm) and a,bmethylene ADP (2 mm) were dissolved in ACSF (Gordon 1986; Cunha et al. 1994; Dawicki et al. 1997; Prior et al. 1997; Sato et al. 1997a; Sato et al. 1997b) .
Microprobe implantation
Rats were anesthetized with 65 mg/kg Nembutal, and their core body temperatures were maintained at 368C with a homeothermic heating blanket from Harvard Apparatus. Anesthesia was maintained with intravenous sodium pentobarbital administered through the jugular vein at 0.25±2 mg/min.
Microprobes with 1-mm-gap distances were introduced into animals in a manner similar to that reported previously for implanting microdialysis probes in the spinal cord of rats (Skilling et al. 1988; Sluka and Westlund 1992) . The T13 vertebra was cleared of muscle and a small hole was drilled into the lateral aspect to expose a small portion of the spinal cord. A piece of 175-mm diameter stainless steel wire (Small Parts, Inc.) was threaded through the microprobe as a guide cannula. One end of the microprobe was inserted into a length of PE20 tubing and secured with epoxy. ACSF was¯ushed through the tubing and the microprobe once the epoxy had dried. On the other end of the microprobe, the extended length of stainless steel guide cannula was secured in place with Super Glue (Elmer's Products, Inc., Columbus, OH, USA). The microprobe was inserted transversely across the dorsal horn of the spinal cord through holes and then ®xed to the bone with dental cement (Lang Dental MFG Co., Wheeling, IL, USA). The guide cannula was removed, the end inserted into a 17-cm length of PE20 tubing pre-®lled with ACSF and the connection secured with epoxy resin.
Push±pull experiments Four 2.5-mL syringes with 26-G needles were connected to two Omni®t 4-port distribution valves (Cambridge, England) by PE20 tubing. The pump was operated at 10 mL/min and samples were collected every 15 min. Collected samples were ®ltered through 0.2-mm polyethersulfone (PSU; Whatman, Clifton, NJ, USA) or nylon (Osmonics Inc./MSI, Westborough, MA, USA) ®lters into 0.5 mL microcentrifuge tubes and placed on dry ice. Samples of stock ACSF and drugs used for each animal were also ®ltered and put on dry ice. All samples were stored between 270 and 2858C until analysis.
Three groups of control animals were tested. One group received ACSF for one hour and 3 mm AMP for two hours (n 3). A second group received ACSF for one hour, 3 mm AMP for the second hour and ACSF for the third hour (n 2). A third group, received ACSF for two hours and 2 mm a,b-methylene ADP, the ecto-5 H -nucleotidase inhibitor, for one hour (n 4). Experimental animals received ACSF for one hour, 0.3 mm (n 5), 1 mm (n 6) or 3 mm (n 5) AMP for the second hour and the same dose of AMP co-administered with 2 mm a,b-methylene ADP for the third hour.
Histological evaluation
Methylene blue was perfused through the microprobe for 15 min after collection of the last sample. Animals were killed with an overdose of Nembutal. Spinal cords, surrounding vertebrae and muscle were dissected and preserved in 10% neutral buffered formalin. The tissue was rinsed with running water and then transferred to a vial containing 10 mL 45% formic acid and 80% sodium citrate (Preece 1965; Page et al. 1990; Callis and Sterchi 1998) . Formic acid solution was changed every 12 h for 36 h, after which the tissue was rinsed in running water and then preserved with 30% sucrose in 0.9% saline. The tissue was sliced in 20-mm slices with a Leica CM 3050 cryostat (Leica Instruments, Nussloch, Germany) at 2208C and transferred to microscope slides. Tissue slices were allowed to dry overnight and were subsequently stained with the nuclear stain, neutral red.
Adenosine collected due to soluble ecto 5
H -nucleotidase 45 mL of 5 mm AMP was incubated with 1 mL of either 5
H -nucleotidase (3 U/mL) in water, water or a collected sample for 45 min at room temperature. Three samples from each of two animals receiving 0.3 mm AMP and three samples from each of two animals receiving 1 mm AMP were collected. Solutions were then derivatized and analyzed in the same manner as the rest of the collected samples.
Analytical measurements
Adenosine and AMP concentrations in collected samples were determined by HPLC analysis with¯uorescence detection. A precolumn derivatization reaction was performed by mixing 45 mL of sample with 2 mL of 0.5 m sodium acetate buffer (pH 6.0), 2 mL of 3.346 nm standard solution of adenosine monosulfate (AMS), and 2 mL of 50% chloroacetaldehyde. The AMS was added as an internal standard. The reaction mixture was allowed to react at 808C for 40 min, after which the derivatized samples were immediately transferred to ice. Samples were ®ltered through 0.2 mm PSU or nylon ®lters before injection onto the HPLC column.
Separations and detection were performed with a Shimadzu (Columbia, MD, USA) HPLC system equipped with an SIL 10 ADVP auto-injector, a 2.1-mm diameter Supelco (Bellefonte, PA, USA) LC-18 analytical column and a Shimadzu RF-10AXL uorescence detector. The auto-injector maintained the samples at 48C prior to analysis, and the pump maintained a¯ow rate of 0.3 mL/min. Triplicate 15-mL injections were made of each sample. The elution pattern consisted of a 50-min linear gradient from 100% mobile phase A (60 mm pH 6.0 potassium phosphate buffer) to 100% mobile phase B (50% 60 mm pH 6.0 phosphate buffer and 50% methanol). This elution pro®le provided adequate separation of ATP, ADP, AMP, AMS, adenosine and cyclic AMP. Elution was detected by a¯uorescent measurement with excitation at 330 nm and emission at 420 nm. Concentrations were determined by comparing peak height ratios (sample to AMS) with a linear calibration model established with standard solutions.
Statistical analysis
Although push±pull solution changes were always made at 50 and 110 min, a small air bubble was not introduced to separate thē uids and there was mixing between the solutions as they traversed the tubing. Samples collected at 60, 105 and 165 min were selected as representative of baseline values, AMP values and AMP plus inhibitor values, respectively. Data were analyzed with a repeated measure anova followed by Tukey's post hoc test for differences between groups. Within each group receiving AMP, a priori paired t-tests were used to compare adenosine concentrations at 60 min with those at 105 min, and adenosine concentrations at 105 min with those at 165 min.
Antihyperalgesia produced by AMP
Placement of microdialysis ®bers
Microdialysis ®bers were used to continuously deliver AMP to the spinal cord in an effort to determine whether AMP could reverse secondary mechanical hyperalgesia produced by intradermal capsaicin. Previous experiments show that various pharmacological agents can be administered to the dorsal spinal cord via microdialysis ®bers (Sluka 1997a; Sluka 1997b) . A high dose of AMP was required to overcome the diffusion barrier of the microdialysis ®ber.
Microdialysis ®bers were prepared from 20-cm lengths of Filtral AN 69 HF membranes. The ®bers were securely suspended and two 1-mm-wide marks were made 2 mm apart. The ®ber was coated with epoxy except for the area between the marks, allowed to dry for 30 minutes, and used the same day.
Animals were anesthetized with 65 mg/kg Nembutal. Microdialysis ®bers were implanted in a manner similar to that used for the microprobe and similar to other published methodologies (Skilling et al. 1988; Sluka and Westlund 1992) . After implantation, the incision was closed with MikRon w AutoClips w (Clay Adams/Becton, Dickinson and Company, Sparks, MD, USA) and saline perfused through the microdialysis ®ber until the animal recovered from anesthesia. Animals were allowed to recover for 12±24 h before behavioral experiments were performed.
Drugs and chemicals 8-Cyclopentyl-1,3-dimethylxanthine (CPT) is not soluble in ACSF at doses that block adenosine A 1 receptor agonists (Cui et al. 1997; Poon and Sawynok 1998) , therefore saline was chosen as the vehicle. Saline (0.9%) was prepared with doubly distilled water (Millipore; Bedford, MA, USA). CPT was purchased from Research Biochemicals International (Natick, MA, USA). AMP (sodium salt) was purchased from Sigma. The pH of the solutions were adjusted to neutral pH (7.0±7.3) with HCl or NaOH and ®ltered through 0.2-mm nylon syringe ®lters.
Behavioral experiments
Animals were allowed to acclimate to the testing environment for 1 h before microdialysis was started. Saline (pH 7) was perfused through the microdialysis tubing for 15 min (5 mL/min), after which the baseline paw withdrawal threshold was determined with a series of Von Frey ®laments (420, 140, 94, 60, 53, 43, 27, 17, 12 and 8 mN) (Sluka 1997a; Sluka 1997b) . The threshold was de®ned as the minimal force from which the animal withdrew the tested paw. Licking of the paw or vocalization were also considered to be positive responses.
After the baseline withdrawal threshold was determined, microdialysis was brie¯y interrupted and 100 mL of 0.1% capsaicin (Fluka, Milwaukee, WI, USA) was injected into the proximal aspect of the plantar surface of one hindpaw using a 0.5-mL tuberculin syringe. After injection, saline was infused for 60 min and withdrawal thresholds evaluated every 15 min. Sixty minutes after capsaicin injection, the infusion solution was changed to either saline (n 7), 1 mm AMP (AMP, n 7), 1 mm CPT (CPT, n 7) or 1 mm AMP in combination with 1 mm CPT (AMP 1 CPT, n 6). Response thresholds were determined every 15 min for 1 h. At the end of the experiment, the spinal cord was removed and placed in 10% formalin for veri®cation of the placement of the microdialysis ®bers. All ®bers were located in the lumbar enlargement of the spinal cord.
Statistical analysis
A Krukal±Wallis test was used to compare group effects at baseline, 60 min and 120 min. This was followed by an a priori Wilcoxon signed ranks test between saline and CPT, between AMP and saline, and between AMP and AMP 1 CPT. The Wilcoxon signed ranks test was used to compare baseline, 60 min and 120 min thresholds within groups.
Results
Micro-probe characterization
As seen in Fig. 2(a) , recovery of p-nitrophenol from the microcentrifuge tube (analyte recovery) increased with increasing gap distance (F 2,6 15.112, p 0.0001), but analyte recovery did not have a signi®cant dependence on ow rate (F 2,6 0.838, p 0.445). Microprobes with a 1-mm gap distance had greater analyte recovery than microprobes with a 0.5-mm gap distance (p 0.02). Microprobes with a 2-mm gap distance had greater analyte recovery than those with a 0.5-mm gap distance (p 0.0001) and 1 mm gap distance (p 0.042).
The recovery of p-nitrophenol from the in¯ow stream (substrate recovery) by the microprobe depended both on gap distance and¯ow rate. As seen in Fig. 2(b) , substrate recovery decreased with increasing gap distance (F 2,6 8.736, p 0.001) and increased with increasinḡ ow rate (F 2,6 7.109, p 0.004). Microprobes with a gap distance of 2 mm had a lower substrate recovery than microprobes with a gap distance of 0.5 mm (p 0.008) or 1 mm (p 0.002). Additionally, substrate recovery at 20 mL/min was signi®cantly different than that at 5 mL/ min (p 0.003).
The microprobe allows for a greater analyte recovery than does microdialysis (Table 1) . The 2-mm gap distance microprobe has a similar analyte recovery as the push±pull cannula, even though the distance between the tips of the push±pull cannula is approximately 0.7 mm.
Gap distance did not have a signi®cant effect on the amount of p-nitrophenol formed by ALP (F 2,6 0.878, p 0.428), however,¯ow rate did (F 2,6 35.833, p 0.0001). p-Nitrophenol formation decreased with increasing¯ow rate (Fig. 3a) . There was signi®cantly more p-nitrophenol collected in experiments when there was ALP in the sol-gel compared with those sol-gels that contained only buffer (p 0.0001, Fig. 3b) .
The amount of unreacted p-nitrophenylphosphate substrate collected was signi®cantly dependent on¯ow rate (F 2,6 33.064, p 0.0001) and not on gap distance (F 2,6 1.052, p 0.365). A higher percentage of substrate was recovered from those sol-gels that did not contain ALP (p 0.0001). The amount of substrate that diffused away and was lost was less than 30% (data not shown). This value was independent of gap distance (F 2,6 0.158, p 0.855), but decreased with increasing¯ow rate (F 2,6 9.834, p 0.001). Calculating the amount of product formed as a result of enzyme activity in the collected samples demonstrated that less than 5% of product collected was because of formation by soluble enzyme (data not shown). This amount was independent of gap distance (p 0.130) and decreased with increasing¯ow rates (p 0.0001).
Enzymatic conversion of AMP to adenosine
In all animals studied, samples collected had an initially elevated adenosine concentration that decreased within 60 min. In the group of animals that received 3 mm AMP for the last two hours, adenosine concentrations increased with the administration of AMP and remained elevated (Fig. 4) . In the group of animals that received 3 mm AMP for only the second hour, adenosine concentrations increased only during the second hour (Fig. 4) . In the group of animals that received two hours of ACSF followed by one hour of 2 mm a,b-methylene ADP, there was no difference between the adenosine concentration in samples collected at 60 min, 105 min and 165 min (p 0.065, Fig. 5 ).
Adenosine concentrations prior to AMP infusion (60 min), after AMP infusion (105 min) and after AMP plus a,b-methylene ADP infusion (165 min) are illustrated in Fig. 5 . Repeated measures anova revealed a group effect for those animals receiving AMP and control animals receiving ACSF for 2 h and 1 h of 2 mm a,b-methylene ADP (p , 0.0001). Tukey's post hoc analysis demonstrated no signi®cant difference between any of the groups prior to infusion of AMP (60 min). There was a signi®cant increase in adenosine concentration in the groups receiving 0.3 mm AMP (p 0.049), 1 mm AMP (p 0.0001) and 3 mm AMP (p 0.0001) compared with those receiving ACSF at 105 min. Additionally, a signi®cant difference in adenosine concentrations between the groups receiving 3 mm, coadministered with 2 mm a,b-methylene ADP, and those receiving only 2 mm a,b-methylene ADP (p 0.006) was observed. Signi®cant differences within groups of adenosine concentrations across time were found for the 0.3 mm group H -nucleotidase activity in the samples (data not shown). Preliminary results using the microprobe demonstrate that AMP is converted to adenosine in the ventral spinal cord (n 3), however, a,b-methylene ADP did not inhibit conversion as strongly as it did in the dorsal horn. Methylene blue perfused through the microprobe for 15 min was seen to localize in the dorsal horn of the spinal cord (Fig. 6) . The greatest amount of methylene blue was observed unilaterally in the super®cial dorsal horn.
AMP effects on mechanical hyperalgesia
Capsaicin produced a signi®cant decrease in the mechanical withdrawal threshold in control animals that received only saline infusion (p 0.018), which remained signi®cantly decreased when compared with baseline at 120 min (p 0.028) and was speci®c to the side of injection (Fig. 7a ). An effect for group was observed 120 min after injection of capsaicin (x 2 9.8, p 0.020), but not at baseline (x 2 2.037, p 0.565) or at 60 min (x 2 3.270, p 0.352). Withdrawal thresholds after 1 h of administration of AMP were signi®cantly higher than in saline treated animals (p 0.043, Fig. 7b ). The effect of AMP was not immediate and response thresholds slowly increased over the hour of AMP administration (Fig. 7a) . There was no difference in the withdrawal thresholds at 120 min between animals receiving saline and those receiving the adenosine A 1 receptor antagonist, CPT (p 0.310). When AMP and CPT were administered together, withdrawal thresholds were signi®cantly lower than they were for animals treated with AMP alone (p 0.043). There was no signi®cant difference between the CPT and AMP 1 CPT groups (p 0.465).
Interestingly, in the AMP 1 CPT group of animals the mechanical withdrawal threshold in the contralateral paw decreased in 66.7% of animals. This effect occured to a lesser degree with CPT alone, and in fewer animals (28.6%). There was no signi®cant difference in the response threshold of the contralateral hindpaw between any of the groups before capsaicin injection (x 2 1.161, p 0.762), 60 min (x 2 3.699, p 0.296) or 120 min after capsaicin injection (x 2 5.012, p 0.171).
Discussion
Transverse push±pull microprobe design and characterization Adenosine has been sampled in a variety of animal tissue structures using microdialysis. Recovery values indicate that 10±30% recovery occurs (Ballarõ Ân et al. 1987; Ballarõ Ân et al. 1991; Chen et al. 1992; Pazzagli et al. 1993; HerreraMarschitz et al. 1994; Blay et al. 1997; Maguire et al. 1998; Liu and Sawynok 1999) . Basal adenosine concentrations are reported to be between 165^22 nm (Sweeney et al. 1990 ) and 191^69 nm (Sweeney et al. 1991) in the intrathecal space of rats. Another more recent report suggests that adenosine concentrations in rat cerebrospinal¯uid are only 90^10 nm (Dobolyi et al. 1998) . With a 10% recovery across microdialysis ®bers, the detection limit would need to be 9±20 nm. This is at or below the detection limit of most HPLC methods. Preliminary experiments measured recovery values across a microdialysis ®ber of only 1% (data not shown). This low recovery would require signi®cantly more sensitive detection methodology. Different sampling techniques were therefore considered. Several techniques including push±pull (Oku et al. 1987; Zachariou and Goldstein 1996) and microdialysis with pin holes (Liu et al. 1998) were considered for sampling the extracellular¯uid in the spinal cord. The concept of push± pull perfusion was developed by Fox and Hilton in 1958 (Myers 1972 ) and has been utilized and advanced by many researchers. The advantage of push±pull perfusion over microdialysis is that exchange between the perfusate and the extracellular¯uid is not limited by diffusion through a membrane. There are very few reports of push±pull experiments in the spinal cord. All of the reports involve performing a laminectomy on an anesthetized animal and lowering the cannula into the dorsal horn of the spinal cord. The initial published study involved push±pull perfusion of the cuneate nucleus of a cat using a cannula that was 0.56 mm in diameter (Gold®nger et al. 1984) . More recent studies used push±pull perfusion to examine substance P release in the rat spinal cord using a cannula of 0.8 mm in diameter, which is very large in relationship to the diameter of the entire spinal cord (Oku et al. 1987; Zachariou and Goldstein 1996) .
In comparison with microdialysis, the microprobe described in this study enables a much larger analyte recovery and depends primarily on gap distance. Larger gap distances allow for greater sampling of the bulk media. Substrate recovery depends on both the gap distance and thē ow rate. The larger gap distances allow for the substrate to leave the microprobe and mix with the surrounding¯uid. Values for substrate recovery can be used to estimate the amount of substrate delivered to tissue. Push±pull cannulas are often used for drug delivery and because the ends of the push±pull cannula are oriented in the same direction, the substrate delivered increases with increasing¯ow rate. The ends of the microprobe are located across from each other resulting in a greater recovery of substrate, while still allowing sampling of bulk media. Additionally, the microprobe has a smaller diameter than push±pull cannulas.
When used to sample conversion of substrate to product by an immobilized enzyme, recovery of product by the microprobe has a strong dependence on gap distance. This is likely to be the result of a dynamic balance of the gap distance dependence of analyte recovery, the mixed gap distance and¯ow rate dependence of substrate recovery, enzyme activity and diffusion through the sol-gel matrix.
The microprobe provides neuroscientists with a novel methodology to sample the extracellular environment without the drawbacks of low recovery experienced with microdialysis. Additionally, it allows investigators to sample neuropeptides that may not diffuse through traditional microdialysis materials. Further development of the microprobe may allow researchers to use the probe in awake, behaving animals.
AMP conversion to adenosine in vivo
The microprobe was used to determine whether AMP could be metabolized to adenosine by ecto-5 H -nucleotidase in the dorsal horn of the spinal cord. The enzyme 5
H -nucleotidase has a molecular mass of approximately 61 kDa and is fairly ubiquitous. The membrane bound form, 
ecto-5
H -nucleotidase, faces the extracellular space (Zimmerman 1992) and is speci®cally inhibited by a,b-methylene ADP (Luzio et al. 1986 ).
The ecto-5 H -nucleotidase enzyme is likely involved in metabolism of adenine nucleotides to adenosine (Bruns 1980a; Gordon et al. 1986; Sato et al. 1997b) . Speci®cally, Bruns demonstrated that AMP, ATP and ADP, but not cyclic AMP, is metabolized to adenosine and produces elevations of intracellular cyclic AMP concentrations, and that the action of these nucleotides is prevented by the ecto-5 H -nucleotidase inhibitor, a,b-methylene ADP (Bruns 1980a) . A recent report suggests adenosine A 1 receptors adjust extracellular adenosine concentrations by regulating ecto-5 H -nucleotidase activity (Andresen et al. 1999 ). Fastbom argues that ecto-5
H -nucleotidase and adenosine receptors are not always co-localized (Fastbom et al. 1987) , however, he did not examine the spinal cord. Others suggest that ecto-5
H -nucleotidase may also play a role in cell±cell interactions (Zimmerman 1992) .
Samples collected from animals within one hour of microprobe implantation revealed elevated adenosine concentrations. Presumably this elevated adenosine is caused by cellular trauma. Similar increases in extracellular adenosine occur in models of traumatic brain and spinal cord injuries (McAdoo et al. 1997; Bell et al. 1998; Xu et al. 1998) . Elevated adenosine concentrations are transient and decrease within 60 min.
Animals receiving AMP for one or two hours clearly demonstrate adenosine is produced only when AMP is present in the perfusion solution. Additionally, adenosine concentrations do not decrease over a 2-h time period of constant AMP perfusion. This suggests that the ecto-5 Hnucleotidase does not become inhibited by accumulating concentrations of AMP in the tissue. This is important for several reasons. First of all, the kinetics of the conversion reaction are very fast. As soon as AMP is introduced, adenosine is produced and collected. Secondly, extracellular adenosine metabolism and uptake mechanisms are very ef®cient. As soon as the AMP is removed from the animal, adenosine levels decrease rapidly and excess adenosine does not remain in the extracellular space.
There is a clear dose-dependent increase in adenosine concentration in samples collected from animals receiving increasing AMP concentrations in the perfusion solution. Adenosine concentration decreases when the ecto-5 Hnucleotidase inhibitor, a,b-methylene ADP, is included in the perfusion solution. Samples collected from animals with the microprobe did not contain soluble 5 H -nucleotidase activity. This suggests that adenosine in the samples was converted from AMP in the extracellular space of the spinal cord and not in the sample itself.
In these experiments, a,b-methylene ADP does not completely inhibit the conversion of AMP to adenosine. The dose used in these experiments is estimated to be the IC 75 (Sato et al. 1997b) , although reported IC 50 values for a,b-methylene ADP vary widely and are reported as 19 nm (Dieckhoff et al. 1986) , 37 nm (Bruns 1980b ) and 410 nm (Sato et al. 1997b) . There is also a report of the IC 80 at 100 nm (Barman 1969) . One report suggests that maximal inhibition of ecto-5 H -nucleotidase is 88% (Sato et al. 1997b ). While others report 85% inhibition in the presence of 10 mm AMP with 1 mm a,b-methylene ADP and 100% inhibition with 10 mm AMP (Bruns 1980b) . Some investigators used even higher concentrations (50±200 mm) in the presence of 10 mm AMP (Cunha and Sebastia Äo 1991) . In the current study, higher concentrations of a,b-methylene ADP were not used because they caused interference with the chromatography.
An alternate explanation for the incomplete inhibition of the conversion of AMP to adenosine relates to the presence of many extracellular phosphatases that may non-speci®-cally convert AMP to adenosine. In biochemical assays, concavalin A and b-glycerophosphate are used to differentiate between 5
H -nucleotidase and other phosphatases (Cook et al. 1982; Gordon et al. 1986; Ellis 1987) . Further experiments could be designed to determine whether alkaline phosphatase is active in the dorsal horn.
Although our results suggest ecto-5 H -nucleotidase is involved in the conversion of AMP to adenosine in the dorsal horn of the spinal cord of rats, it is not known if this action is speci®c for the dorsal horn. 5
H -nucleotidase distribution in the mouse has been demonstrated by the addition of AMP and lead acetate, which precipitates lead phosphate and is visualized as lead sul®de. 5
H -nucleotidase activity is found throughout the rat spinal cord with very high levels in the substantia gelatinosa of the spinal cord (Scott 1965) . More recent studies localized 5 H -nucleotidase activity to the lateral white matter columns, interfascicular oligodendroglia, myelinated ®bers and blood vessels in rat spinal cord (Cammer et al. 1985) and the dorsal horn of the spinal cord (Nagata et al. 1984 ). Another study found 5 Hnucleotidase activity in the dorsal root ganglion, demonstrating localization in primary afferents (Nagy and Daddona 1985) .
One limitation of the usefulness of the microprobe may be the placement of the microprobe. Figure 6 illustrates the placement of the microprobe such that the gap completely overlaps the dorsal horn of the spinal cord. Variation in the placement of the microprobe may decrease the reproducibility in analyte concentrations collected with the microprobe. Previously, Westlund and colleagues showed lower concentrations of glutamate in the super®cial dorsal horn as compared with concentrations in the deep dorsal horn (unpublished observations, personal communication).
Behavioral effects of AMP in vivo
Administration of saline via microdialysis produced transient agitation in all animals tested, probably because of the large difference in osmolarity and diffusion of endogenous compounds into the microdialysis ®ber creating a disruption of the extracellular milieu. However, baseline withdrawal thresholds after 15 min of saline were similar to those previously reported (Sluka 1997a; Sluka 1997b; Sluka and Willis 1997) . Injection of capsaicin into the hindpaw reduced the mechanical withdrawal threshold at a site distal to the area of injection. The reduced mechanical withdrawal threshold in the ipsilateral hindpaw is interpreted as secondary mechanical hyperalgesia. These results are comparable with other studies utilizing this model of in¯amma-tory pain in rats (Sluka 1997a; Sluka 1997b; Sluka and Willis 1997; Larson and Kitto 1999) .
Over the interval of 1 h, 1 mm AMP reversed the secondary mechanical hyperalgesia in injected animals. Withdrawal thresholds 2 h after capsaicin injection were comparable with baseline values before capsaicin injection. The effect of AMP was blocked by the adenosine A 1 receptor antagonist, CPT, suggesting that CPT blocked the action of AMP. CPT has been used to speci®cally block adenosine A 1 receptors (Lee and Yaksh 1996; Cui et al. 1997; Nakamura et al. 1997; Khandwala et al. 1998) . Therefore, these results suggest the antihyperalgesic action of AMP is speci®c to adenosine A 1 receptor activation.
Adenosine A 1 receptors are in higher density in the dorsal horn than in the ventral horn (Geiger et al. 1984) , with the greatest density in the substantia gelatinosa (Goodman and Snyder 1982) . Adenosine A 1 receptors play an active role in antihyperalgesia (Lee and Yaksh 1996; Cui et al. 1997; Poon and Sawynok 1998) . N 6 -(R-Phenylisopropyl)adenosine, an adenosine A 1 receptor agonist, produces a dosedependent allodynia in a spinal ligation model of tactile allodynia that is blocked by the adenosine A 1 receptor antagonist, CPT (Lee and Yaksh 1996) . This is reported for a sciatic chronic constriction injury model of tactile allodynia as well (Cui et al. 1997) . In a carrageenan model of thermal hyperalgesia, the adenosine A 1 receptor agonist, N 6 -cyclohexyladenosine, produces antihyperalgesia that is reversed by the adenosine A 1 receptor antagonist CPT but not the adenosine A 2 receptor antagonist, 3,7-dimethyl-1-propargyl xanthine (Poon and Sawynok 1998 ). Our studies demonstrate that AMP acts via adenosine A 1 receptors to reverse the secondary mechanical hyperalgesia produced by intradermal capsaicin. AMP is not thought to act directly at adenosine A 1 receptors (Bruns 1980a; Yegutkin and Burnstock 1999) .
There is no known mechanism for release of AMP into the extracellular space (Zimmerman 1992) although others suggest secretion (Rosenberg and Li 1996) . As AMP is the last precursor to adenosine in any proposed metabolic pathway for the production of adenosine, involvement of other nucleotides cannot be ruled out. Administration of ADP and cyclic AMP, via microdialysis to animals after secondary hyperalgesia is induced, would further delineate the metabolic source of adenosine in the rat dorsal horn.
In summary, we have developed and characterized a push±pull microprobe that can be used to sample the extracellular space of the spinal cord. With this microprobe we have demonstrated that AMP is converted to adenosine in the dorsal horn of the rat spinal cord and that this conversion is inhibited by the ecto-5 H -nucleotidase inhibitor, a,b-methylene ADP. Additionally, AMP reverses secondary mechanical hyperalgesia produced by intradermal capsaicin, and this reversal is inhibited by the speci®c adenosine A 1 receptor antagonist, CPT. Finally, we conclude that AMP is converted to adenosine in the dorsal horn of the spinal cord by ecto-5
H -nucleotidase and subsequently may be one source of adenosine acting through adenosine A 1 receptors in the dorsal horn of the spinal cord to produce antihyperalgesia.
